Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.12.08 | Sapiens Announces Payment of Third Installment of the Principal Amount of Debentures | 20 | PR Newswire | CARY, North Carolina, December 7 /PRNewswire-FirstCall/ -- Sapiens International Corporation N.V. , a member of the Formula Group , today announced that it has paid the third installment of the principal... ► Artikel lesen | |
07.12.08 | Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL | 30 | PR Newswire | SAN FRANCISCO, Dec. 7 /PRNewswire-FirstCall/ -- Results of the Phase 2 clinical trial of R788 (fostamatinib disodium) in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma (NHL) will... ► Artikel lesen | |
07.12.08 | Rentrak Theatrical Announces Box Office Estimates for Weekend of December 7, 2008 | 25 | PR Newswire | LOS ANGELES, Dec. 7 /PRNewswire-FirstCall/ -- Rentrak Theatrical, a business unit of Rentrak Corporation , today announced the weekend theatrical box office estimates for the weekend period of December... ► Artikel lesen | |
07.12.08 | First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting | 70 | PR Newswire | CHESHIRE, Conn., Dec. 7 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. for the treatment of paroxysmal nocturnal hemoglobinuria... ► Artikel lesen | |
07.12.08 | DAIICHI SANKYO Initiates Phase III Trial of its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation | 21 | PR Newswire | TOKYO, MUNICH, Germany and EDISON, New Jersey, December 7 /PRNewswire/ --
- ENGAGE-AF TIMI 48 Trial to Study 16,500 Patients in More Than 1,400
Centers Globally
DAIICHI SANKYO Company... ► Artikel lesen | |
07.12.08 | Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology | 21 | PR Newswire | SAN FRANCISCO, Dec. 7 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. today announced the presentation of new data from two ongoing clinical trials demonstrating that the company's novel drug... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 2.561 |
NEL | 1.501 |
APPLE | 1.410 |
BYD | 1.316 |
BAYER | 1.313 |
SUPER MICRO COMPUTER | 1.230 |
DEUTSCHE BANK | 1.126 |
TUI | 1.094 |
NVIDIA | 1.074 |
PLUG POWER | 936 |
TESLA | 895 |
DAIMLER TRUCK | 886 |
MERCEDES-BENZ | 825 |
RWE | 794 |
RHEINMETALL | 784 |
AURUBIS | 745 |
RENK GROUP | 709 |
VOLKSWAGEN | 702 |
DEUTSCHE LUFTHANSA | 694 |
COMMERZBANK | 681 |
AMAZON | 653 |
SIEMENS ENERGY | 637 |
AIXTRON SE | 603 |
SIXT SE VZ | 592 |
BASF | 550 |